Individual meropenem epithelial lining fluid and plasma PK/PD target attainment
Antimicrobial Agents and Chemotherapy · 14.12.2023 · 67 (12)
DOI: 10.1128/aac.00727-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 14.12.2023. Verfasst von Roxane Rohani und 14 weiteren Autor:innen. Beteiligte Einrichtung: Discipline of Cellular and Molecular Pharmacology, Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, Illin…. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Pseudomonas Infections. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIAID NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
It is unclear whether plasma is a reliable surrogate for target attainment in the epithelial lining fluid (ELF). The objective of this study was to characterize meropenem target attainment in plasma and ELF using prospective samples. The first 24-hour T >MIC was evaluated vs 1xMIC and 4xMIC targets at the patient (i.e., fixed MIC of 2 mg/L) and population [i.e., cumulative fraction of response (CFR) according to EUCAST MIC distributions] levels for both plasma and ELF. Among 65 patients receiving ≥24 hours of treatment, 40% of patients failed to achieve >50% T >4xMIC in plasma and ELF, and 30% of patients who achieved >50% T >4xMIC in plasma had 4xMIC in ELF. At 1xMIC and 4xMIC targets, 3% and 25% of patients with >95% T >MIC in plasma had MIC in ELF, respectively. Those with a CRCL >115 mL/min were less likely to achieve >50%T >4xMIC in ELF ( P < 0.025). In the population, CFR for Escherichia coli at 1xMIC and 4xMIC was >97%. For Pseudomonas aeruginosa , CFR was ≥90% in plasma and ranged 80%–85% in ELF at 1xMIC when a loading dose was applied. CFR was reduced in plasma (range: 75%–81%) and ELF (range: 44%–60%) in the absence of a loading dose at 1xMIC. At 4xMIC, CFR for P. aeruginosa was 60%–86% with a loading dose and 18%–62% without a loading dose. We found that plasma overestimated ELF target attainment inup to 30% of meropenem-treated patients, CRCL >115 mL/min decreased target attainment in ELF, and loading doses increased CFR in the population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Discipline of Cellular and Molecular Pharmacology, Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois, USA.
- Optimal Data Analysis, LLC, Chicago, Illinois, USA.
- Department of Pharmacy Practice, Midwestern University, Chicago College of Pharmacy, Downers Grove, Illinois, USA.
- Pharmacometrics Center of Excellence, Midwestern University, Downers Grove, Illinois, USA.
- Department of Pharmacy, Northwestern Memorial Hospital, Chicago, Illinois, USA.
- Laboratory of Applied Pharmacokinetics and Bioinformatics, The Saban Research Institute, Children's Hospital of Los Angeles, Los Angeles, California, USA.
ORCID-Profile: Roxane Rohani, Paul R Yarnold, Marc H Scheetz, Michael N Neely, Mengjia Kang, Helen K Donnelly, Alan R Hauser, Egon A Ozer, Alexander V Misharin, Richard G Wunderink, Nathaniel J Rhodes
Förderung
- NIA NIH HHS
- NIAID NIH HHS
- NHLBI NIH HHS
- NCATS NIH HHS
- NLM NIH HHS
- HHS | National Institutes of Health
- Midwestern University
Zitieren
APA
Rohani, R., Yarnold, P. R., Scheetz, M. H., Neely, M. N., Kang, M., Donnelly, H. K., Dedicatoria, K., Nozick, S. H., Medernach, R. L., Hauser, A. R., Ozer, E. A., Diaz, E., Misharin, A. V., Wunderink, R. G., & Rhodes, N. J. (2023). Individual meropenem epithelial lining fluid and plasma PK/PD target attainment. Antimicrobial Agents and Chemotherapy, 67(12). https://doi.org/10.1128/aac.00727-23
Vancouver
Rohani R, Yarnold PR, Scheetz MH, Neely MN, Kang M, Donnelly HK, et al. Individual meropenem epithelial lining fluid and plasma PK/PD target attainment. Antimicrobial Agents and Chemotherapy. 2023;67(12). doi:10.1128/aac.00727-23
BibTeX
@article{Rohani2023,
author = {Rohani, Roxane and Yarnold, Paul R and Scheetz, Marc H and Neely, Michael N and Kang, Mengjia and Donnelly, Helen K and Dedicatoria, Kay and Nozick, Sophie H and Medernach, Rachel L and Hauser, Alan R and Ozer, Egon A and Diaz, Estefani and Misharin, Alexander V and Wunderink, Richard G and Rhodes, Nathaniel J},
title = {Individual meropenem epithelial lining fluid and plasma PK/PD target attainment},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2023},
volume = {67},
number = {12},
doi = {10.1128/aac.00727-23}
}
EUVIMED